Document Mentions (4 shared documents)

EFTA00136746

2 mentions1 same-page

Page ?Same page

Wall Street Journal <https://wwvv.wsj.corn/articles/house-committee-says-u-s-spy-agencies-are-failing- china-challenge-11601478089> (9/30, O'Keeffe, Strobel, Subscription Publication, 7.57M) reports that in a statement, DNI Ratcliffe said, "I'm glad to see that there's congressional recognition of what I

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

EFTA00135712

2 mentions1 same-page

Page ?Same page

CCP makes decisions, and fail to respond effectively. The good news is that we still have time to adapt." The Wall Street Journal. (9/30, O'Keeffe, Strobel, Subscription Publication, 7.57M) reports that in a statement, DNI Ratcliffe said, "I'm glad to see that there's congressional recognition of what

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

EFTA00148896

2 mentions1 same-page

Page ?Same page

CCP makes decisions, and fail to respond effectively. The good news is that we still have time to adapt." The Wall Street Journal (9/30, O'Keeffe, Strobel, Subscription Publication, 7.57M) reports that in a statement, DNI Ratcliffe said, "I'm glad to see that there's congressional recognition of what

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human